
### [MONDO:0020105](http://purl.obolibrary.org/obo/MONDO_0020105)
**Label:** hemolytic anemia due to hexose monophosphate shunt and glutathione metabolism anomalies

**Subclasses:** [MONDO:0009947](http://purl.obolibrary.org/obo/MONDO_0009947) (glutathione synthetase deficiency with 5-oxoprolinuria), [MONDO:0009284](http://purl.obolibrary.org/obo/MONDO_0009284) (glutathione synthetase deficiency without 5-oxoprolinuria), [MONDO:0019531](http://purl.obolibrary.org/obo/MONDO_0019531) (hemolytic anemia due to glutathione reductase deficiency), [MONDO:0017909](http://purl.obolibrary.org/obo/MONDO_0017909) (glutathione synthetase deficiency), [MONDO:0009259](http://purl.obolibrary.org/obo/MONDO_0009259) (gamma-glutamylcysteine synthetase deficiency), [MONDO:0020457](http://purl.obolibrary.org/obo/MONDO_0020457) (6-phosphogluconate dehydrogenase deficiency), 

**Corr. equiv. classes:** [OMIM:230450](http://purl.obolibrary.org/obo/OMIM_230450), [OMIM:266130](http://purl.obolibrary.org/obo/OMIM_266130), [Orphanet:99135](http://www.orpha.net/ORDO/Orphanet_99135), [Orphanet:289849](http://www.orpha.net/ORDO/Orphanet_289849), [Orphanet:289846](http://www.orpha.net/ORDO/Orphanet_289846), [Orphanet:32](http://www.orpha.net/ORDO/Orphanet_32), [OMIM:231900](http://purl.obolibrary.org/obo/OMIM_231900), [Orphanet:90030](http://www.orpha.net/ORDO/Orphanet_90030), [Orphanet:33574](http://www.orpha.net/ORDO/Orphanet_33574), 

**Class expressions from DL-Learner:**

- [HP:0003343](http://purl.obolibrary.org/obo/HP_0003343) (Glutathione synthetase deficiency) 66.67%
- [HP:0003343](http://purl.obolibrary.org/obo/HP_0003343) (Glutathione synthetase deficiency) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 66.67%
- [HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia) and [HP:0003343](http://purl.obolibrary.org/obo/HP_0003343) (Glutathione synthetase deficiency) 66.67%
- [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) and [HP:0003343](http://purl.obolibrary.org/obo/HP_0003343) (Glutathione synthetase deficiency) 66.67%
- [HP:0001877](http://purl.obolibrary.org/obo/HP_0001877) (Abnormality of erythrocytes) and [HP:0003343](http://purl.obolibrary.org/obo/HP_0003343) (Glutathione synthetase deficiency) 66.67%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0003343](http://purl.obolibrary.org/obo/HP_0003343) (Glutathione synthetase deficiency) 66.67%
- [HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia) 32.85%
- [HP:0001877](http://purl.obolibrary.org/obo/HP_0001877) (Abnormality of erythrocytes) 32.58%
- [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 31.06%
- [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) 31.06%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 30.70%
- [HP:0000007](http://purl.obolibrary.org/obo/HP_0000007) (Autosomal recessive inheritance) and [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) 29.58%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 28.92%
- Thing 28.91%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 28.91%


